Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $30.55 Analyst target: $45.88 Upside: 50.18%
Agios Pharmaceuticals, Inc., a biopharmaceutical company, is dedicated to drug discovery and development in the field of cellular metabolism and adjacent areas of biology. The company is headquartered in Cambridge, Massachusetts.
See the full interactive analysis & chart →Informational only — not investment advice.